Inhibition of warfarin activity by ribavirin

Annals of Pharmacotherapy

Volumn 36, Issue 1, 2002, Pages 72-74

  Schulman, Sam ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hepatitis C; Interferon; Ribavirin; Warfarin

Indexed keywords

ALPHA2B INTERFERON; RIBAVIRIN; WARFARIN;

ADULT; ANTICOAGULATION; ARTICLE; CASE REPORT; DOSE CALCULATION; DRUG CROSS REACTIVITY; HEART VALVE REPLACEMENT; HEPATITIS C; HUMAN; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME;

EID: 0036143586     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A181     Document Type: Article

References (10)

1. Potentiation of warfarin by interferon
2. A method for estimating the probability of adverse drug reactions
3. +-nucleoside purine (N) transporter
4. Ribavirin uptake by human erythrocytes and the involvement of nitrobensylthioinosine-sensitive (es)-nucleoside transporters
5. The metabolism of ribavirin in erythrocytes and nucleated cells
6. Pharmacokinetics of ribavirin and urinary excretion of the major metabolite 1,2,4-trazole-3-carboxamide in normal volunteers
7. Oral anticoagulation
8. Enhanced elimination of warfarin during treatment with cholestyramine
9. Ribavirin and interferon alpha-2b in chronic hepatitis C: Assessment of possible pharmacokinetic and pharmacodynamic interactions